Corporate Social Responsibility in Ranbaxy Laboratories

Only available on StudyMode
  • Download(s) : 503
  • Published : April 3, 2013
Open Document
Text Preview
|
Corporate Social Responsibility Report: RANBAXY LABORATORIES LTD| |

ABSTRACT

This report explores the Millennium Development Goals related to Healthcare at global and national level. It also focuses on the diseases that are prevalent in India and the steps taken by Ranbaxy towards the eradication of these diseases. It reviews the activities of Ranbaxy Laboratories towards the welfare of community and the protection of environment. It also throws light on the efforts done by the company in playing its part in fulfilling the Millennium Development Goals that directly affect or are affected by its business. It also looks towards the company’s approach towards sustainable development.

CONTENTS
i. Abstract………………………………………………….……………………………………1 1. Global Health Report Card …………………………………………………………………..3 2.1. Child Mortality Rate.……………………………………………….................................3 2.2. HIV/AIDS.…………………………………………………………................................3 2.3. Tuberculosis.……………………………………………………………………………..4 2.4. Maternal Mortality Rate.…………………………………………...................................4 2.5. Malaria.……………………………………………………………..................................5 2.6. Lifestyle Diseases ………………………………………………….................................5 2. Snapshot of Pharmaceutical Industry at Global and National Level ………...........................6 3.7. Research and Development……………………………………………………………...6 3.8. Industry’s contribution to developing world’s diseases……………................................6 3.9. Global pharmaceutical market…………………………………………………………...6 3.10. India’s pharmaceutical industry………………………………………………………….7 3. Ranbaxy Laboratories Limited…………………………………………….............................8 4.11. GoodGuide.com…………………………………………………………………………8 4.12. ATM Index………………………………………………………………………………8 4. Ranbaxy Community Health Care…………………………………………............................9 5.13. Health care initiatives………………………………………………................................9 5.14. Anti-Malaria project……………………………………………….................................10 5.15. Anti-HIV/AIDS project………………………………………………………………...10 5. Workplace Initiatives………………………………………………………………………...11 6. Environment Activities………………………………………………………………………11 7.16. Investments in green technologies………………………………………………………11 7.17. Global standards compliance……………………………………………………………12 7.18. Wastewater Management………………………………………………………………..12 7. Critical analysis……………………………………………………………............................13 8. Annexure……………………………………………………………………..........................15

GLOBAL HEALTH REPORT CARD
CHILD MORTALITY
Child mortality continues to decline worldwide. The total number of deaths of children under 5 years old fell from 12.4 million in 1990 to 8.1 million in 2009. The levels of mortality in children under 5 years old in the African Region and in low-income countries are still the highest in the world and higher than the 1990 global level of 89 per 1000 live births. Pneumonia and diarrheal diseases are the two biggest killers of children under 5 years old, accounting for 18% and 15% of all deaths respectively in 2008. Annually, 1.64 million children dying under the age of 5 years die in India. Table 1

Source: WHO Health Report 2011 As per Table 1, the situation of child mortality is the worst in African Region and more than two-thirds of deaths are preventable. Malnutrition and the lack of safe water and sanitation contribute to half of all these children’s deaths. Research and experience show that most of the children who die each year could be saved by low-tech, evidence-based, cost-effective measures such as vaccines, antibiotics, micronutrient supplementation, insecticide-treated bed nets, improved family care and oral rehydration therapy.

HIV\AIDS
The Acquired...
tracking img